Skip to main content
Premium Trial:

Request an Annual Quote

Gene Check Nabs $2M NIST Grant to Develop Novel Genotyping Technology

NEW YORK, Oct. 2 (GenomeWeb News) - Colorado-based genotyping-technology company Gene Check has won a $2 million National Institute of Standards and Technology grant to develop a method that can  simultaneously detect "up to 100,000" SNPs in patient DNA.

 

Terms of the three-year project call for Gene Check to develop a "low-cost method for accurately detecting and genotyping up to 100,000 SNPs in a single DNA sample," the company said in a statement.

 

Ultimately, the goal is to devise SNP-detection technology that will genotype more than 20 SNPs per second in a fully automated system at less than $0.02 per SNP. This would enable researchers to genotype 100,000 SNPs for less than $2,000 in less than three hours using off-the-shelf-instrumentation, Gene Check said.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.